AREDIA
LOE ApproachingNDAINJECTIONINJECTABLE
Approved
Sep 1998
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed 20h ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
AREDIA (pamidronate disodium) is an intravenous bisphosphonate approved in 1998 for treating hypercalcemia of malignancy and osteolytic bone metastases in multiple myeloma and breast cancer. It works by inhibiting osteoclast-mediated bone resorption and reducing serum calcium levels. This small-molecule injectable addresses serious metabolic complications in oncology patients.
LOE Approaching
Product is in late-stage lifecycle with moderate competitive pressure (30/100), indicating potential team consolidation and shift toward retention and managed decline strategies.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on AREDIA at this lifecycle stage means focusing on defensive commercial strategies, managed care negotiations, and cost-per-dose optimization rather than growth and market expansion. Career value lies in specialty pharmacy expertise, payer relations, and experience managing mature oncology products through competitive and generic-pressure environments.
Brand Manager
Worked on AREDIA at Novartis? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.